TORONTO, Jan. 14, 2008 (PRIME NEWSWIRE) -- Cannasat Therapeutics ("Cannasat" or the "Company") (TSX-V:CTH), the developer of novel cannabinoid-based pharmaceutical products, today announced that Dr. Julia Levy has been appointed to its Board of Directors. Dr. Levy is a Canadian pharmaceutical industry leader and brings years of drug discovery, development, and commercialization experience to the Cannasat Board.
